Categories
AltogenLabs
About CRO
We are Altogen Labs, a preclinical CRO based in Austin, Texas, focused on oncology and early‑stage drug discovery. We offer in vivo and in vitro services to support pharmacology, safety, and mechanism‑of-action studies, especially for small biotechs and academic partners.
Core Services:
Xenograft efficacy models (CDX, PDX)
In vivo toxicology (mouse, rat)
Bio‑analytical and PK/PD support
Stable cell line development
RNAi / siRNA delivery and in vivo gene silencing
Assay development (ELISA, cell‑based)
Why Researchers Choose Us:
We provide deep oncology model expertise with 50+ validated xenograft models tailored to translational work.
Our lab supports IND‑enabling safety studies under GLP.
We specialize in RNAi delivery (siRNA/shRNA) with both in vitro and in vivo platforms.
Our team is flexible and collaborative, working with small biotechs to tailor study design, from pilot to regulatory package.
Technology & Expertise
GLP‑compliant in vivo toxicology facility Patient-derived xenograft (PDX) and cell-line xenograft (CDX) models Liposome-based delivery systems for RNAi molecules Stable cell line generation (protein overexpression or RNAi knockdown) In vitro molecular biology (gene expression, siRNA/CRISPR) Bioanalytical PK/PD and safety readouts
Core Services
Xenograft models (efficacy) Safety / toxicology studies Stable cell line engineering RNAi-based model development & delivery Assay development & validation Bioanalysis / PK/PD
Accreditations & Compliance
GLP‑compliant toxicology studies, IACUC-regulated animal handling for in vivo studies , Full client IP ownership on study data
